28.53

3.78% -1.12

After Hours: 28.53

Claritev Corp (CTEV)

Overview News Price History Discussions Forecast

Claritev Corp stock is traded at $28.53, with a volume of 140.59K. It is down -3.78% in the last 24 hours and up +75.68% over the past month. Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Previous Close:

$29.65

Open:

$29.5

24h Volume:

140.59K

Relative Volume:

0.80

Market Cap:

$486.37M

Revenue:

$965.41M

Net Income/Loss:

$-284.28M

P/E Ratio:

-1.6494

EPS:

-17.2969

Net Cash Flow:

$-12.28M

1W Performance:

+8.19%

1M Performance:

+75.68%

6M Performance:

-51.33%

1Y Performance:

+30.81%

1-Day Range:

$28.50

$31.67

1-Week Range:

$22.88

$31.70

52-Week Range:

$12.04

$74.07

Claritev Corp Stock (CTEV) Company Profile

Name

Claritev Corp

Sector

Healthcare (1106)

Industry

Health Information Services (50)

Phone

212-780-2000

Address

7900 TYSONS ONE PLACE, MCLEAN

Employee

3,000

Twitter

Next Earnings Date

2026-05-07

Latest SEC Filings

CTEV's Discussions on Twitter

Compare CTEV vs VEEV, BTSG, TEM, HQY, DOCS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTEV Claritev Corp	28.53	505.47M	965.41M	-284.28M	-12.28M	-17.30
VEEV Veeva Systems Inc	159.42	26.00B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	55.50	10.68B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	46.95	8.70B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	80.46	6.90B	1.31B	215.20M	408.32M	2.4627
DOCS Doximity Inc	26.45	4.85B	637.78M	239.40M	307.21M	1.1909

Claritev Corp Stock (CTEV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-24-26	Initiated	Barclays	Overweight
Jan-12-26	Initiated	Guggenheim	Buy
Jan-09-26	Initiated	Wells Fargo	Equal Weight
Oct-21-25	Upgrade	Citigroup	Neutral → Buy
May-29-25	Upgrade	Piper Sandler	Neutral → Overweight
Jun-26-24	Initiated	Piper Sandler	Neutral
Dec-13-22	Downgrade	Citigroup	Buy → Neutral
Jul-12-22	Initiated	Goldman	Neutral
Oct-04-21	Resumed	Citigroup	Buy
Apr-07-21	Initiated	B. Riley Securities	Buy
Mar-19-21	Initiated	Barclays	Equal Weight

View All

Claritev Corp Stock (CTEV) Latest News

May 12, 2026

Claritev targets $80M-$100M ACV bookings in 2026 while raising revenue outlook to $985M-$1B - MSN

May 11, 2026

Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026 - Business Wire

May 11, 2026

May 09, 2026

Claritev (CTEV) Gets a Buy from Barclays - The Globe and Mail

May 09, 2026

May 08, 2026

Q1 2026 Claritev Corp Earnings Call Transcript - GuruFocus

May 08, 2026

Claritev Narrows FY26 View To Rev $985M-$1B >CTEV - Moomoo

May 08, 2026

Top Claritev (CTEV) Competitors 2026 - MarketBeat

May 08, 2026

Guggenheim Maintains Claritev(CTEV.US) With Buy Rating, Maintains Target Price $38 - Moomoo

May 08, 2026

Barclays Maintains Claritev(CTEV.US) With Buy Rating, Maintains Target Price $28 - Moomoo

May 08, 2026

Claritev Corporation (CTEV) Stock Analysis: A Promising 64% Upside In Healthcare Tech - DirectorsTalk Interviews

May 08, 2026

Claritev (CTEV) Q1 2026 Loss Of US$4.41 Per Share Tests Bullish Margin Narratives - simplywall.st

May 08, 2026

Claritev Corp (CTEV)

Claritev Corp Stock (CTEV) Company Profile

Compare CTEV vs VEEV, BTSG, TEM, HQY, DOCS

Claritev Corp Stock (CTEV) Upgrades & Downgrades

Claritev Corp Stock (CTEV) Latest News

Claritev Q1 Earnings Call Highlights - MSN

Claritev Earnings Call Signals AI-Fueled Growth Path - The Globe and Mail

Citigroup Upgrades Claritev (CTEV) - MSN

Claritev targets $80M-$100M ACV bookings in 2026 while raising revenue outlook to $985M-$1B - MSN

Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026 - Business Wire

Claritev (CTEV) Gets a Buy from Barclays - The Globe and Mail

Q1 2026 Claritev Corp Earnings Call Transcript - GuruFocus

Claritev Narrows FY26 View To Rev $985M-$1B >CTEV - Moomoo

Top Claritev (CTEV) Competitors 2026 - MarketBeat

Guggenheim Maintains Claritev(CTEV.US) With Buy Rating, Maintains Target Price $38 - Moomoo

Barclays Maintains Claritev(CTEV.US) With Buy Rating, Maintains Target Price $28 - Moomoo

Claritev Corporation (CTEV) Stock Analysis: A Promising 64% Upside In Healthcare Tech - DirectorsTalk Interviews

Claritev (CTEV) Q1 2026 Loss Of US$4.41 Per Share Tests Bullish Margin Narratives - simplywall.st

Claritev Q1 2026 slides: revenue rises 5.8% amid volume headwinds By Investing.com - Investing.com South Africa

Claritev Earnings Call Highlights Growth, AI and Deals - TipRanks

Claritev : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

Claritev Q1 2026 slides: revenue rises 5.8% amid volume headwinds - Investing.com

Claritev Corporation Q1 2026 Earnings Call Summary - Yahoo Finance

Claritev Corp 1Q 2026: Revenue $244.68M, Net income ($73.56M), EPS ($4.41) — 10-Q Summary - TradingView

[10-Q] Claritev Corp Quarterly Earnings Report - Stock Titan

Claritev (CTEV) Q1 2026 Earnings Transcript - AOL.com

Claritev Corporation (CTEV) reports Q1 loss, tops revenue estimates - MSN

Claritev Corporation 2026 Q1ResultsEarnings Call Presentation (NYSE:CTEV) 2026-05-07 - Seeking Alpha

Earnings call transcript: Claritev’s Q1 2026 shows strong revenue growth - Investing.com

CTEV: Q1 delivered robust growth, record bookings, and raised guidance, fueled by AI and market expansion - TradingView

CTEV: Strong Q1 growth, record bookings, and AI-driven efficiency support raised 2026 outlook - TradingView

Earnings call transcript: Claritev’s Q1 2026 shows strong revenue growth By Investing.com - Investing.com Canada

Claritev (NYSE:CTEV) Slides Premarket Despite Q1 Revenue Beat as Net Loss Widens - ChartMill

CTEV: Q1 2026 revenue rose 5.8% year-over-year, with strong client retention and AI-driven growth - TradingView

Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Claritev Q1 2026 Earnings Call Transcript - MarketBeat

Claritev : Q1 2026 Results and Business Update - marketscreener.com

Claritev Corporation Releases First Quarter 2026 Financial Results on May 7 - geneonline.com

CLARITEV ($CTEV) Releases Q1 2026 Earnings - Quiver Quantitative

Claritev (NYSE: CTEV) grows Q1 revenue and reaffirms EBITDA outlook - Stock Titan

Claritev Corporation Reports First Quarter 2026 Results - The Joplin Globe

BRIEF-Claritev Corp Q1 Revenue USD 244.678 Million - TradingView

Claritev Corporation Raises Its Full Year 2026 Guidance - marketscreener.com

Claritev Q1 2026 earnings preview - MSN

Claritev Corp expected to post a loss of $4.01 a shareEarnings Preview - TradingView

How The Claritev (CTEV) Story Is Shifting As Analysts Trim Targets Yet Stay Positive - Yahoo Finance

CTEV SEC FilingsClaritev Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Claritev Cares Opens Rural Health Grants, Continuing Three Decades of Investment in Underserved Communities - The National Law Review

Earnings Preview: Claritev to Report Financial Results Pre-market on May 07 - 富途牛牛

Claritev Stockholders OK Directors, PwC and Pay Plan at 2026 Virtual Annual Meeting - MarketBeat

Claritev Shareholders Expand Incentive Plan, Back Board Slate - The Globe and Mail

Claritev Corp (CTEV) director granted 8,977 restricted stock units in new award - Stock Titan

Claritev Corp (CTEV) director awarded 8,977 RSUs, updates indirect holdings - Stock Titan

Claritev Corp (CTEV) director receives 8,977 restricted stock units - Stock Titan

Claritev (CTEV) director granted 8,977 restricted stock units - Stock Titan

Claritev Corp (CTEV) director awarded 8,977 restricted stock units - Stock Titan

Claritev Corp Stock (CTEV) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to CTEV